Skip to main content
SpringerLink
Log in

NF-κB in colorectal cancer

  • Review
  • Published:
Journal of Molecular Medicine Aims and scope Submit manuscript

Abstract

Colorectal cancer (CRC) is a leading cause of morbidity and mortality worldwide, responsible for more than half a million deaths annually. CRC is a multistep process that entails the accumulation of genetic/epigenetic aberrations, which lead to the simultaneous failure of protective mechanisms and the activation of tumorigenic pathways. In most cases of CRC a deregulation of the Wnt-signaling pathway is required. The transcription factor nuclear factor κB (NF-κB) has been recognized as a key player in the initiation and propagation of CRC. Under physiological conditions, NF-κB orchestrates the inflammatory process and participates in the modulation of various steps of cell cycle and survival. It is normally kept in an inactive state in the cytoplasm by binding to a group of inhibitory proteins. Upon receipt of a signal, its inhibitor is phosphorylated and proteolytically degraded and NF-κB is actively translocated to the nucleus, where it facilitates target-gene transcription. Recent experimental data reveal the important role of NF-κB in tumor cells as well as in the surrounding “cancerous” and reactive microenvironment. Various tumor cell-derived and contextual cues feed constantly this vicious circuitry sustaining inflammation and promoting proliferation, angiogenesis, invasion and eventually metastasis. Therefore NF-κB along with its upstream and downstream network presents a rational target for therapeutic interventions. Numerous small molecules, inhibitory peptides, antisense RNAs, natural compounds, as well as gene therapy strategies interfere with multiple steps of the NF-κΒ signaling cascade. The design of NF-κΒ-targeted treatment may aid the efforts towards the pursuit of more efficient therapeutic measures devoid of severe systemic side-effects.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D (2011) Global cancer statistics. CA Cancer J Clin 61:69–90

    Article  PubMed  Google Scholar 

  2. Vaiopoulos AG, Kostakis ID, Koutsilieris M, Papavassiliou AG (2012) Colorectal cancer stem cells. Stem Cells 30:363–371

    Article  PubMed  CAS  Google Scholar 

  3. Vaiopoulos AG, Papachroni KK, Papavassiliou AG (2010) Colon carcinogenesis: Learning from NF-kappaB and AP-1. Int J Biochem Cell Biol 42:1061–1065

    Article  PubMed  CAS  Google Scholar 

  4. Hinz M, Arslan SC, Scheidereit C (2012) It takes two to tango: IkappaBs, the multifunctional partners of NF-kappaB. Immunol Rev 246:59–76

    Article  PubMed  Google Scholar 

  5. Smale ST (2011) Hierarchies of NF-kappaB target-gene regulation. Nat Immunol 12:689–694

    Article  PubMed  CAS  Google Scholar 

  6. Perkins ND (2012) The diverse and complex roles of NF-kappaB subunits in cancer. Nat Rev Cancer 12:121–132

    PubMed  CAS  Google Scholar 

  7. Aggarwal BB, Sung B (2011) NF-kappaB in cancer: a matter of life and death. Cancer Discov 1:469–471

    Article  PubMed  CAS  Google Scholar 

  8. Prasad S, Ravindran J, Aggarwal BB (2010) NF-kappaB and cancer: how intimate is this relationship. Mol Cell Biochem 336:25–37

    Article  PubMed  CAS  Google Scholar 

  9. Chaturvedi MM, Sung B, Yadav VR, Kannappan R, Aggarwal BB (2011) NF-kappaB addiction and its role in cancer: 'one size does not fit all'. Oncogene 30:1615–1630

    Article  PubMed  CAS  Google Scholar 

  10. Thomasova D, Mulay SR, Bruns H, Anders HJ (2012) p53-independent roles of MDM2 in NF-kappaB signaling: implications for cancer therapy, wound healing, and autoimmune diseases. Neoplasia 14:1097–1101

    PubMed  CAS  Google Scholar 

  11. Grivennikov SI, Greten FR, Karin M (2010) Immunity, inflammation, and cancer. Cell 140:883–899

    Article  PubMed  CAS  Google Scholar 

  12. Schneider G, Kramer OH (2011) NFkappaB/p53 crosstalk-a promising new therapeutic target. Biochim Biophys Acta 1815:90–103

    PubMed  CAS  Google Scholar 

  13. Xiao G, Fu J (2011) NF-kappaB and cancer: a paradigm of Yin-Yang. Am J Cancer Res 1:192–221

    PubMed  CAS  Google Scholar 

  14. Ben-Neriah Y, Karin M (2011) Inflammation meets cancer, with NF-kappaB as the matchmaker. Nat Immunol 12:715–723

    Article  PubMed  CAS  Google Scholar 

  15. Pasparakis M (2012) Role of NF-kappaB in epithelial biology. Immunol Rev 246:346–358

    Article  PubMed  Google Scholar 

  16. Grivennikov SI (2013) Inflammation and colorectal cancer: colitis-associated neoplasia. Semin Immunopathol 35:229–244

    Article  PubMed  CAS  Google Scholar 

  17. Bollrath J, Greten FR (2009) IKK/NF-kappaB and STAT3 pathways: central signalling hubs in inflammation-mediated tumour promotion and metastasis. EMBO Rep 10:1314–1319

    Article  PubMed  CAS  Google Scholar 

  18. Klampfer L (2011) Cytokines, inflammation and colon cancer. Curr Cancer Drug Targets 11:451–464

    Article  PubMed  CAS  Google Scholar 

  19. Terzic J, Grivennikov S, Karin E, Karin M (2010) Inflammation and colon cancer. Gastroenterology 138:2101–2114

    Article  PubMed  CAS  Google Scholar 

  20. Sunami Y, Wirth T (2011) Intestinal carcinogenesis: IKK can go all the way. J Clin Invest 121:2551–2553

    Article  PubMed  CAS  Google Scholar 

  21. Gyrd-Hansen M, Meier P (2010) IAPs: from caspase inhibitors to modulators of NF-kappaB, inflammation and cancer. Nat Rev Cancer 10:561–574

    Article  PubMed  CAS  Google Scholar 

  22. Vlantis K, Wullaert A, Sasaki Y, Schmidt-Supprian M, Rajewsky K, Roskams T, Pasparakis M (2011) Constitutive IKK2 activation in intestinal epithelial cells induces intestinal tumors in mice. J Clin Invest 121:2781–2793

    Article  PubMed  CAS  Google Scholar 

  23. Schwitalla S, Fingerle AA, Cammareri P, Nebelsiek T, Göktuna SI, Ziegler PK, Canli O, Heijmans J, Huels DJ, Moreaux G et al (2013) Intestinal tumorigenesis initiated by dedifferentiation and acquisition of stem-cell-like properties. Cell 152:25–38

    Article  PubMed  CAS  Google Scholar 

  24. Guma M, Stepniak D, Shaked H, Spehlmann ME, Shenouda S, Cheroutre H, Vicente-Suarez I, Eckmann L, Kagnoff MF, Karin M (2011) Constitutive intestinal NF-kappaB does not trigger destructive inflammation unless accompanied by MAPK activation. J Exp Med 208:1889–1900

    Article  PubMed  CAS  Google Scholar 

  25. Shaked H, Hofseth LJ, Chumanevich A, Chumanevich AA, Wang J, Wang Y, Taniguchi K, Guma M, Shenouda S, Clevers H et al (2012) Chronic epithelial NF-kappaB activation accelerates APC loss and intestinal tumor initiation through iNOS up-regulation. Proc Natl Acad Sci U S A 109:14007–14012

    Article  PubMed  CAS  Google Scholar 

  26. Puvvada SD, Funkhouser WK, Greene K, Deal A, Chu H, Baldwin AS, Tepper JE, O'Neil BH (2010) NF-kB and Bcl-3 activation are prognostic in metastatic colorectal cancer. Oncology 78:181–188

    Article  PubMed  CAS  Google Scholar 

  27. Kwon HC, Kim SH, Oh SY, Lee S, Kwon KA, Lee JH, Choi HJ, Park KJ, Lee HS, Roh MS et al (2010) Clinicopathological significance of nuclear factor-kappa B, HIF-1 alpha, and vascular endothelial growth factor expression in stage III colorectal cancer. Cancer Sci 101:1557–1561

    Article  PubMed  CAS  Google Scholar 

  28. Grivennikov SI, Karin M (2011) Inflammatory cytokines in cancer: tumour necrosis factor and interleukin 6 take the stage. Ann Rheum Dis 70(Suppl 1):i104–i108

    Article  PubMed  CAS  Google Scholar 

  29. Sethi G, Shanmugam MK, Ramachandran L, Kumar AP, Tergaonkar V (2012) Multifaceted link between cancer and inflammation. Biosci Rep 32:1–15

    Article  PubMed  CAS  Google Scholar 

  30. Wu Y, Zhou BP (2010) TNF-alpha/NF-kappaB/Snail pathway in cancer cell migration and invasion. Br J Cancer 102:639–644

    Article  PubMed  CAS  Google Scholar 

  31. Grivennikov SI, Karin M (2010) Dangerous liaisons: STAT3 and NF-kappaB collaboration and crosstalk in cancer. Cytokine Growth Factor Rev 21:11–19

    Article  PubMed  CAS  Google Scholar 

  32. Ernst M, Ramsay RG (2012) Colorectal cancer mouse models: integrating inflammation and the stroma. J Gastroenterol Hepatol 27:39–50

    Article  PubMed  CAS  Google Scholar 

  33. Lin G, Tang Z, Ye YB, Chen Q (2012) NF-kappaB activity is downregulated by KRAS knockdown in SW620 cells via the RAS-ERK-IkappaBalpha pathway. Oncol Rep 27:1527–1534

    PubMed  CAS  Google Scholar 

  34. Lin G, Zheng XW, Li C, Chen Q, Ye YB (2012) KRAS mutation and NF-κB activation indicates tolerance of chemotherapy and poor prognosis in colorectal cancer. Dig Dis Sci 57:2325–2333

    Article  PubMed  CAS  Google Scholar 

  35. Daniluk J, Liu Y, Deng D, Chu J, Huang H, Gaiser S, Cruz-Monserrate Z, Wang H, Ji B, Logsdon CD (2012) An NF-κB pathway-mediated positive feedback loop amplifies Ras activity to pathological levels in mice. J Clin Invest 122:1519–1528

    Article  PubMed  CAS  Google Scholar 

  36. Schwitalla S, Ziegler PK, Horst D, Becker V, Kerle I, Begus-Nahrmann Y, Lechel A, Rudolph KL, Langer R, Slotta-Huspenina J et al (2013) Loss of p53 in enterocytes generates an inflammatory microenvironment enabling invasion and lymph node metastasis of carcinogen-induced colorectal tumors. Cancer Cell 23:93–106

    Article  PubMed  CAS  Google Scholar 

  37. Chu D, Zhou Y, Zhang Z, Li Y, Li J, Zheng J, Zhang H, Zhao Q, Wang W, Wang R et al (2011) Notch1 expression, which is related to p65 Status, is an independent predictor of prognosis in colorectal cancer. Clin Cancer Res 17:5686–5694

    Article  PubMed  CAS  Google Scholar 

  38. Astarci E, Sade A, Cimen I, Savaş B, Banerjee S (2012) The NF-κB target genes ICAM-1 and VCAM-1 are differentially regulated during spontaneous differentiation of Caco-2 cells. FEBS J 279:2966–2986

    Article  PubMed  CAS  Google Scholar 

  39. Kang DW, Park MH, Lee YJ, Kim HS, Kwon TK, Park WS, Min do S (2008) Phorbol ester up-regulates phospholipase D1 but not phospholipase D2 expression through a PKC/Ras/ERK/NFkappaB-dependent pathway and enhances matrix metalloproteinase-9 secretion in colon cancer cells. J Biol Chem 283:4094–4104

    Article  PubMed  CAS  Google Scholar 

  40. Porquet N, Poirier A, Houle F, Pin AL, Gout S, Tremblay PL, Paquet ER, Klinck R, Auger FA, Huot J (2011) Survival advantages conferred to colon cancer cells by E-selectin-induced activation of the PI3K-NFκB survival axis downstream of Death receptor-3. BMC Cancer 11:285

    Article  PubMed  CAS  Google Scholar 

  41. Chen Y, Wang Z, Chang P, Xiang L, Pan F, Li J, Jiang J, Zou L, Yang L, Bian Z et al (2010) The effect of focal adhesion kinase gene silencing on 5-fluorouracil chemosensitivity involves an Akt/NF-kappaB signaling pathway in colorectal carcinomas. Int J Cancer 127:195–206

    Article  PubMed  CAS  Google Scholar 

  42. Maeda S, Hikiba Y, Sakamoto K, Nakagawa H, Hirata Y, Hayakawa Y, Akanuma M (2011) Colon cancer-derived factors activate NF-kappaB in myeloid cells via TLR2 to link inflammation and tumorigenesis. Mol Med Rep 4:1083–1088

    PubMed  CAS  Google Scholar 

  43. Charalambous MP, Lightfoot T, Speirs V, Horgan K, Gooderham NJ (2009) Expression of COX-2, NF-kappaB-p65, NF-kappaB-p50 and IKKalpha in malignant and adjacent normal human colorectal tissue. Br J Cancer 101:106–115

    Article  PubMed  CAS  Google Scholar 

  44. Wang TP, Hsu SH, Feng HC, Huang RF (2012) Folate deprivation enhances invasiveness of human colon cancer cells mediated by activation of sonic hedgehog signaling through promoter hypomethylation and cross action with transcription nuclear factor-kappa B pathway. Carcinogenesis 33:1158–1168

    Article  PubMed  Google Scholar 

  45. Miao Z, Zhao T, Wang Z, Xu Y, Song Y, Wu J, Xu H (2012) CARMA3 is overexpressed in colon cancer and regulates NF-κB activity and cyclin D1 expression. Biochem Biophys Res Commun 425:781–787

    Article  PubMed  CAS  Google Scholar 

  46. Allen IC, Wilson JE, Schneider M, Lich JD, Roberts RA, Arthur JC, Woodford RM, Davis BK, Uronis JM, Herfarth HH et al (2012) NLRP12 suppresses colon inflammation and tumorigenesis through the negative regulation of noncanonical NF-κB signaling. Immunity 36:742–754

    Article  PubMed  CAS  Google Scholar 

  47. Gavert N, Vivanti A, Hazin J, Brabletz T, Ben-Ze'ev A (2011) L1-mediated colon cancer cell metastasis does not require changes in EMT and cancer stem cell markers. Mol Cancer Res 9:14–24

    Article  PubMed  CAS  Google Scholar 

  48. Southern SL, Collard TJ, Urban BC, Skeen VR, Smartt HJ, Hague A, Oakley F, Townsend PA, Perkins ND, Paraskeva C et al (2012) BAG-1 interacts with the p50-p50 homodimeric NF-κB complex: implications for colorectal carcinogenesis. Oncogene 31:2761–2772

    Article  PubMed  CAS  Google Scholar 

  49. Gilmore TD, Garbati MR (2011) Inhibition of NF-κB signaling as a strategy in disease therapy. Curr Top Microbiol Immunol 349:245–263

    Article  PubMed  CAS  Google Scholar 

  50. Zhu Z, Zhong S, Shen Z (2011) Targeting the inflammatory pathways to enhance chemotherapy of cancer. Cancer Biol Ther 12:95–105

    Article  PubMed  CAS  Google Scholar 

  51. Wang K, Grivennikov SI, Karin M (2012) Implications of anti-cytokine therapy in colorectal cancer and autoimmune diseases. Ann Rheum Dis. doi:10.1136/annrheumdis-2012-202201

    Google Scholar 

  52. Gallant JN, Allen JE, Smith CD, Dicker DT, Wang W, Dolloff NG, Navaraj A, El-Deiry WS (2011) Quinacrine synergizes with 5-fluorouracil and other therapies in colorectal cancer. Cancer Biol Ther 12:239–251

    Article  PubMed  CAS  Google Scholar 

  53. Liang MC, Bardhan S, Pace EA, Rosman D, Beutler JA, Porco JA Jr, Gilmore TD (2006) Inhibition of transcription factor NF-kappaB signaling proteins IKKbeta and p65 through specific cysteine residues by epoxyquinone A monomer: correlation with its anti-cancer cell growth activity. Biochem Pharmacol 71:634–645

    Article  PubMed  CAS  Google Scholar 

  54. Parada-Turska J, Paduch R, Majdan M, Kandefer-Szerszeń M, Rzeski W (2007) Antiproliferative activity of parthenolide against three human cancer cell lines and human umbilical vein endothelial cells. Pharmacol Rep 59:233–237

    PubMed  CAS  Google Scholar 

  55. Li C, Guo S, Shi T (2012) Role of NF-κB activation in matrix metalloproteinase 9, vascular endothelial growth factor and interleukin 8 expression and secretion in human breast cancer cells. Cell Biochem Funct. doi:10.1002/cbf.2899

    Google Scholar 

  56. Hayakawa Y, Maeda S, Nakagawa H, Hikiba Y, Shibata W, Sakamoto K, Yanai A, Hirata Y, Ogura K, Muto S et al (2009) Effectiveness of IkappaB kinase inhibitors in murine colitis-associated tumorigenesis. J Gastroenterol 44:935–943

    Article  PubMed  CAS  Google Scholar 

  57. Liu T, Liu D, Liu J, Song JT, Gao SL, Li H, Hu LH, Liu BR (2012) Effect of NF-κB inhibitors on the chemotherapy-induced apoptosis of the colon cancer cell line HT-29. Exp Ther Med 4:716–722

    PubMed  CAS  Google Scholar 

  58. Chen D, Frezza M, Schmitt S, Kanwar J, Dou QP (2011) Bortezomib as the first proteasome inhibitor anticancer drug: current status and future perspectives. Curr Cancer Drug Targets 11:239–253

    Article  PubMed  CAS  Google Scholar 

  59. Sprowl JA, Reed K, Armstrong SR, Lanner C, Guo B, Kalatskaya I, Stein L, Hembruff SL, Tam A, Parissenti AM (2012) Alterations in tumor necrosis factor signaling pathways are associated with cytotoxicity and resistance to taxanes: a study in isogenic resistant tumor cells. Breast Cancer Res 14:R2

    Article  PubMed  CAS  Google Scholar 

  60. Togano T, Sasaki M, Watanabe M, Nakashima M, Tsuruo T, Umezawa K, Higashihara M, Watanabe T, Horie R (2009) Induction of oncogene addiction shift to NF-kappaB by camptothecin in solid tumor cells. Biochem Biophys Res Commun 390:60–64

    Article  PubMed  CAS  Google Scholar 

  61. Suboj P, Babykutty S, Valiyaparambil Gopi DR, Nair RS, Srinivas P, Gopala S (2012) Aloe emodin inhibits colon cancer cell migration/angiogenesis by downregulating MMP-2/9, RhoB and VEGF via reduced DNA binding activity of NF-κB. Eur J Pharm Sci 45:581–591

    Article  PubMed  CAS  Google Scholar 

  62. Tas SW, Vervoordeldonk MJ, Tak PP (2009) Gene therapy targeting nuclear factor-kappaB: towards clinical application in inflammatory diseases and cancer. Curr Gene Ther 9:160–170

    Article  PubMed  CAS  Google Scholar 

  63. De Stefano D (2011) Oligonucleotides decoy to NF-kappaB: becoming a reality? Discov Med 12:97–105

    PubMed  Google Scholar 

  64. Kuo YC, Lin WC, Chiang IT, Chang YF, Chen CW, Su SH, Chen CL, Hwang JJ (2012) Sorafenib sensitizes human colorectal carcinoma to radiation via suppression of NF-κB expression in vitro and in vivo. Biomed Pharmacother 66:12–20

    Article  PubMed  CAS  Google Scholar 

  65. Dia VP, Gonzalez de Mejia E (2011) Lunasin potentiates the effect of oxaliplatin preventing outgrowth of colon cancer metastasis, binds to α5β1 integrin and suppresses FAK/ERK/NF-κB signaling. Cancer Lett 313:167–180

    Article  PubMed  CAS  Google Scholar 

  66. Kang HW, Kim JM, Cha MY, Jung HC, Song IS, Kim JS (2012) Deguelin, an Akt inhibitor, down-regulates NF-κB signaling and induces apoptosis in colon cancer cells and inhibits tumor growth in mice. Dig Dis Sci 57:2873–2882

    Article  PubMed  CAS  Google Scholar 

  67. Souissi I, Najjar I, Ah-Koon L, Schischmanoff PO, Lesage D, Le Coquil S, Roger C, Dusanter-Fourt I, Varin-Blank N, Cao A et al (2011) A STAT3-decoy oligonucleotide induces cell death in a human colorectal carcinoma cell line by blocking nuclear transfer of STAT3 and STAT3-bound NF-κB. BMC Cell Biol 12:14. doi:10.1186/1471-2121-12-14

    Article  PubMed  CAS  Google Scholar 

  68. Konstantinopoulos PA, Vandoros GP, Sotiropoulou-Bonikou G, Kominea A, Papavassiliou AG (2007) NF-kappaB/PPAR gamma and/or AP-1/PPAR gamma 'on/off' switches and induction of CBP in colon adenocarcinomas: correlation with COX-2 expression. Int J Colorectal Dis 22:57–68

    Article  PubMed  Google Scholar 

  69. Ban JO, Kwak DH, Oh JH, Park EJ, Cho MC, Song HS, Song MJ, Han SB, Moon DC, Kang KW et al (2010) Suppression of NF-kappaB and GSK-3beta is involved in colon cancer cell growth inhibition by the PPAR agonist troglitazone. Chem Biol Interact 188:75–85

    Article  PubMed  CAS  Google Scholar 

  70. Luqman S, Pezzuto JM (2010) NFkappaB: a promising target for natural products in cancer chemoprevention. Phytother Res 24:949–963

    PubMed  CAS  Google Scholar 

  71. Shakibaei M, Mobasheri A, Lueders C, Busch F, Shayan P, Goel A (2013) Curcumin Enhances the Effect of Chemotherapy against Colorectal Cancer Cells by Inhibition of NF-κB and Src Protein Kinase Signaling Pathways. PLoS One 8:e57218. doi:10.1371/journal.pone.0057218

    Article  PubMed  CAS  Google Scholar 

  72. Yadav VR, Prasad S, Sung B, Gelovani JG, Guha S, Krishnan S, Aggarwal BB (2012) Boswellic acid inhibits growth and metastasis of human colorectal cancer in orthotopic mouse model by downregulating inflammatory, proliferative, invasive and angiogenic biomarkers. Int J Cancer 130:2176–2184

    Article  PubMed  CAS  Google Scholar 

  73. Al-Halabi R, Bou Chedid M, Abou Merhi R, El-Hajj H, Zahr H, Schneider-Stock R, Bazarbachi A, Gali-Muhtasib H (2011) Gallotannin inhibits NFĸB signaling and growth of human colon cancer xenografts. Cancer Biol Ther 12:59–68

    Article  PubMed  CAS  Google Scholar 

  74. Prasad S, Yadav VR, Sung B, Reuter S, Kannappan R, Deorukhkar A, Diagaradjane P, Wei C, Baladandayuthapani V, Krishnan S et al (2012) Ursolic acid inhibits growth and metastasis of human colorectal cancer in an orthotopic nude mouse model by targeting multiple cell signaling pathways: chemosensitization with capecitabine. Clin Cancer Res 18:4942–4953

    Article  PubMed  CAS  Google Scholar 

  75. Nagendraprabhu P, Sudhandiran G (2011) Astaxanthin inhibits tumor invasion by decreasing extracellular matrix production and induces apoptosis in experimental rat colon carcinogenesis by modulating the expressions of ERK-2, NFkB and COX-2. Invest New Drugs 29:207–224

    Article  PubMed  CAS  Google Scholar 

  76. Abaza MS, Bahman AM, Al-Attiyah RJ, Kollamparambil AM (2012) Synergistic induction of apoptosis and chemosensitization of human colorectal cancer cells by histone deacetylase inhibitor, scriptaid, and proteasome inhibitors: potential mechanisms of action. Tumour Biol 33:1951–1972

    Article  PubMed  CAS  Google Scholar 

  77. Shah MA, Power DG, Kindler HL, Holen KD, Kemeny MM, Ilson DH, Tang L, Capanu M, Wright JJ, Kelsen DP (2011) A multicenter, phase II study of bortezomib (PS-341) in patients with unresectable or metastatic gastric and gastroesophageal junction adenocarcinoma. Invest New Drugs 29:1475–1481

    Article  PubMed  CAS  Google Scholar 

Download references

Disclosures

All authors state that they have no conflicts of interest.

Author information

Authors and Affiliations

  1. Department of Biological Chemistry, University of Athens Medical School, 11527, Athens, Greece

    Aristeidis G. Vaiopoulos, Kalliopi Ch. Athanasoula & Athanasios G. Papavassiliou

Authors
  1. Aristeidis G. Vaiopoulos
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Kalliopi Ch. Athanasoula
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Athanasios G. Papavassiliou
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Athanasios G. Papavassiliou.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Vaiopoulos, A.G., Athanasoula, K.C. & Papavassiliou, A.G. NF-κB in colorectal cancer. J Mol Med 91, 1029–1037 (2013). https://doi.org/10.1007/s00109-013-1045-x

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00109-013-1045-x

Keywords

Search

Navigation